FindTrial
Sign In

Optimal vancomycin exposure in neonates with coagulase negative staphylococcus infection: a retrospective study based on medical records

Optimal vancomycin exposure in neonates with coagulase negative staphylococcus infection: a retrospective study based on medical records

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045998
Enrollment
Unknown
Registered
2021-05-02
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Interventions

case series:Nil

Sponsors

Women and Children's Hospital, School of Medicine, Xiamen university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Postpartum age (PNA) <=28 days at admission; 2.The neonate was treated with vancomycin for at least 2 days; 3.At least one serum concentration monitoring value of vancomycin; 4.Demography, blood routine, blood biochemical and other clinical data of the children were complete.

Exclusion criteria

Exclusion criteria: Renal replacement therapy during medication.

Design outcomes

Primary

MeasureTime frame
vancomycin serum concentration;demographics;Blood biochemistry;Blood routine;Etiological examination;MIC measurement;combination;—

Countries

China

Contacts

Public ContactChen Quanyao

Women and Children's Hospital, School of Medicine, Xiamen University

chenquanyao@outlook.com+86 18050194642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026